Laboratory Balances
Laboratory Balances market is segmented by region (country), players, by Type and by Application. ... Read More
1 Study Coverage 1.1 CRISPR/Cas9 Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Introduction 1.2 Global CRISPR/Cas9 Outlook 2017 VS 2022 VS 2028 1.2.1 Global CRISPR/Cas9 Market Size for the Year 2017-2028 1.2.2 Global CRISPR/Cas9 Market Size for the Year 2017-2028 1.3 CRISPR/Cas9 Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States CRISPR/Cas9 in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of CRISPR/Cas9 Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 CRISPR/Cas9 Market Dynamics 1.4.1 CRISPR/Cas9 Industry Trends 1.4.2 CRISPR/Cas9 Market Drivers 1.4.3 CRISPR/Cas9 Market Challenges 1.4.4 CRISPR/Cas9 Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 CRISPR/Cas9 by Type 2.1 CRISPR/Cas9 Market Segment by Type 2.1.1 Genome Editing 2.1.2 Genetic Engineering 2.1.3 gRNA Database/Gene Librar 2.1.4 CRISPR Plasmid 2.1.5 Human Stem Cells 2.1.6 Genetically Modified Organisms/Crops 2.1.7 Cell Line Engineering 2.2 Global CRISPR/Cas9 Market Size by Type (2017, 2022 & 2028) 2.3 Global CRISPR/Cas9 Market Size by Type (2017-2028) 2.4 United States CRISPR/Cas9 Market Size by Type (2017, 2022 & 2028) 2.5 United States CRISPR/Cas9 Market Size by Type (2017-2028) 3 CRISPR/Cas9 by Application 3.1 CRISPR/Cas9 Market Segment by Application 3.1.1 Biotechnology Companies 3.1.2 Pharmaceutical Companies 3.1.3 Academic Institutes 3.1.4 Research and Development Institutes 3.2 Global CRISPR/Cas9 Market Size by Application (2017, 2022 & 2028) 3.3 Global CRISPR/Cas9 Market Size by Application (2017-2028) 3.4 United States CRISPR/Cas9 Market Size by Application (2017, 2022 & 2028) 3.5 United States CRISPR/Cas9 Market Size by Application (2017-2028) 4 Global CRISPR/Cas9 Competitor Landscape by Company 4.1 Global CRISPR/Cas9 Market Size by Company 4.1.1 Top Global CRISPR/Cas9 Companies Ranked by Revenue (2021) 4.1.2 Global CRISPR/Cas9 Revenue by Player (2017-2022) 4.2 Global CRISPR/Cas9 Concentration Ratio (CR) 4.2.1 CRISPR/Cas9 Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of CRISPR/Cas9 in 2021 4.2.3 Global CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global CRISPR/Cas9 Headquarters, Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type 4.3.1 Global CRISPR/Cas9 Headquarters and Area Served 4.3.2 Global CRISPR/Cas9 Companies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into CRISPR/Cas9 Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States CRISPR/Cas9 Market Size by Company 4.5.1 Top CRISPR/Cas9 Players in United States, Ranked by Revenue (2021) 4.5.2 United States CRISPR/Cas9 Revenue by Players (2020, 2021 & 2022) 5 Global CRISPR/Cas9 Market Size by Region 5.1 Global CRISPR/Cas9 Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global CRISPR/Cas9 Market Size by Region (2017-2028) 5.2.1 Global CRISPR/Cas9 Market Size by Region: 2017-2022 5.2.2 Global CRISPR/Cas9 Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America CRISPR/Cas9 Market Size YoY Growth 2017-2028 6.1.2 North America CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific CRISPR/Cas9 Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific CRISPR/Cas9 Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe CRISPR/Cas9 Market Size YoY Growth 2017-2028 6.3.2 Europe CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America CRISPR/Cas9 Market Size YoY Growth 2017-2028 6.4.2 Latin America CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa CRISPR/Cas9 Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Caribou Biosciences 7.1.1 Caribou Biosciences Company Details 7.1.2 Caribou Biosciences Business Overview 7.1.3 Caribou Biosciences CRISPR/Cas9 Introduction 7.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022) 7.1.5 Caribou Biosciences Recent Development 7.2 Integrated DNA Technologies(IDT) 7.2.1 Integrated DNA Technologies(IDT) Company Details 7.2.2 Integrated DNA Technologies(IDT) Business Overview 7.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Introduction 7.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022) 7.2.5 Integrated DNA Technologies(IDT) Recent Development 7.3 CRISPR Therapeutics 7.3.1 CRISPR Therapeutics Company Details 7.3.2 CRISPR Therapeutics Business Overview 7.3.3 CRISPR Therapeutics CRISPR/Cas9 Introduction 7.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) 7.3.5 CRISPR Therapeutics Recent Development 7.4 Merck 7.4.1 Merck Company Details 7.4.2 Merck Business Overview 7.4.3 Merck CRISPR/Cas9 Introduction 7.4.4 Merck Revenue in CRISPR/Cas9 Business (2017-2022) 7.4.5 Merck Recent Development 7.5 Mirus Bio 7.5.1 Mirus Bio Company Details 7.5.2 Mirus Bio Business Overview 7.5.3 Mirus Bio CRISPR/Cas9 Introduction 7.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022) 7.5.5 Mirus Bio Recent Development 7.6 Editas Medicine 7.6.1 Editas Medicine Company Details 7.6.2 Editas Medicine Business Overview 7.6.3 Editas Medicine CRISPR/Cas9 Introduction 7.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022) 7.6.5 Editas Medicine Recent Development 7.7 Takara Bio 7.7.1 Takara Bio Company Details 7.7.2 Takara Bio Business Overview 7.7.3 Takara Bio CRISPR/Cas9 Introduction 7.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022) 7.7.5 Takara Bio Recent Development 7.8 Thermo Fisher Scientific 7.8.1 Thermo Fisher Scientific Company Details 7.8.2 Thermo Fisher Scientific Business Overview 7.8.3 Thermo Fisher Scientific CRISPR/Cas9 Introduction 7.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022) 7.8.5 Thermo Fisher Scientific Recent Development 7.9 Horizon Discovery Group 7.9.1 Horizon Discovery Group Company Details 7.9.2 Horizon Discovery Group Business Overview 7.9.3 Horizon Discovery Group CRISPR/Cas9 Introduction 7.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022) 7.9.5 Horizon Discovery Group Recent Development 7.10 Intellia Therapeutics 7.10.1 Intellia Therapeutics Company Details 7.10.2 Intellia Therapeutics Business Overview 7.10.3 Intellia Therapeutics CRISPR/Cas9 Introduction 7.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) 7.10.5 Intellia Therapeutics Recent Development 7.11 Agilent Technologies 7.11.1 Agilent Technologies Company Details 7.11.2 Agilent Technologies Business Overview 7.11.3 Agilent Technologies CRISPR/Cas9 Introduction 7.11.4 Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022) 7.11.5 Agilent Technologies Recent Development 7.12 Cellecta 7.12.1 Cellecta Company Details 7.12.2 Cellecta Business Overview 7.12.3 Cellecta CRISPR/Cas9 Introduction 7.12.4 Cellecta Revenue in CRISPR/Cas9 Business (2017-2022) 7.12.5 Cellecta Recent Development 7.13 GenScript 7.13.1 GenScript Company Details 7.13.2 GenScript Business Overview 7.13.3 GenScript CRISPR/Cas9 Introduction 7.13.4 GenScript Revenue in CRISPR/Cas9 Business (2017-2022) 7.13.5 GenScript Recent Development 7.14 GeneCopoeia 7.14.1 GeneCopoeia Company Details 7.14.2 GeneCopoeia Business Overview 7.14.3 GeneCopoeia CRISPR/Cas9 Introduction 7.14.4 GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022) 7.14.5 GeneCopoeia Recent Development 7.15 Synthego 7.15.1 Synthego Company Details 7.15.2 Synthego Business Overview 7.15.3 Synthego CRISPR/Cas9 Introduction 7.15.4 Synthego Revenue in CRISPR/Cas9 Business (2017-2022) 7.15.5 Synthego Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. CRISPR/Cas9 Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. CRISPR/Cas9 Market Trends Table 3. CRISPR/Cas9 Market Drivers Table 4. CRISPR/Cas9 Market Challenges Table 5. CRISPR/Cas9 Market Restraints Table 6. Global CRISPR/Cas9 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States CRISPR/Cas9 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global CRISPR/Cas9 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States CRISPR/Cas9 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top CRISPR/Cas9 Companies in Global Market, Ranking by Revenue (2021) Table 11. Global CRISPR/Cas9 Revenue by Player, (US$ Million), 2017-2022 Table 12. Global CRISPR/Cas9 Revenue Share by Player, 2017-2022 Table 13. Global CRISPR/Cas9 Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global CRISPR/Cas9 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR/Cas9 as of 2021) Table 15. Top Players of CRISPR/Cas9 in Global Market, Headquarters and Area Served Table 16. Companies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into CRISPR/Cas9 Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top CRISPR/Cas9 Players in United States Market, Ranking by Revenue (2021) Table 20. United States CRISPR/Cas9 Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States CRISPR/Cas9 Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global CRISPR/Cas9 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global CRISPR/Cas9 Market Size by Region (2017-2022) & (US$ Million) Table 24. Global CRISPR/Cas9 Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific CRISPR/Cas9 Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Caribou Biosciences Company Details Table 31. Caribou Biosciences Business Overview Table 32. Caribou Biosciences CRISPR/Cas9 Product Table 33. Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 34. Caribou Biosciences Recent Development Table 35. Integrated DNA Technologies(IDT) Company Details Table 36. Integrated DNA Technologies(IDT) Business Overview Table 37. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Table 38. Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 39. Integrated DNA Technologies(IDT) Recent Development Table 40. CRISPR Therapeutics Company Details Table 41. CRISPR Therapeutics Business Overview Table 42. CRISPR Therapeutics CRISPR/Cas9 Product Table 43. CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 44. CRISPR Therapeutics Recent Development Table 45. Merck Company Details Table 46. Merck Business Overview Table 47. Merck CRISPR/Cas9 Product Table 48. Merck Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 49. Merck Recent Development Table 50. Mirus Bio Company Details Table 51. Mirus Bio Business Overview Table 52. Mirus Bio CRISPR/Cas9 Product Table 53. Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 54. Mirus Bio Recent Development Table 55. Editas Medicine Company Details Table 56. Editas Medicine Business Overview Table 57. Editas Medicine CRISPR/Cas9 Product Table 58. Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 59. Editas Medicine Recent Development Table 60. Takara Bio Company Details Table 61. Takara Bio Business Overview Table 62. Takara Bio CRISPR/Cas9 Product Table 63. Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 64. Takara Bio Recent Development Table 65. Thermo Fisher Scientific Company Details Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific CRISPR/Cas9 Product Table 68. Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 69. Thermo Fisher Scientific Recent Development Table 70. Horizon Discovery Group Company Details Table 71. Horizon Discovery Group Business Overview Table 72. Horizon Discovery Group CRISPR/Cas9 Product Table 73. Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 74. Horizon Discovery Group Recent Development Table 75. Intellia Therapeutics Company Details Table 76. Intellia Therapeutics Business Overview Table 77. Intellia Therapeutics CRISPR/Cas9 Product Table 78. Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 79. Intellia Therapeutics Recent Development Table 80. Agilent Technologies Company Details Table 81. Agilent Technologies Business Overview Table 82. Agilent Technologies CRISPR/Cas9 Product Table 83. Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 84. Agilent Technologies Recent Development Table 85. Cellecta Company Details Table 86. Cellecta Business Overview Table 87. Cellecta CRISPR/Cas9 Product Table 88. Cellecta Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 89. Cellecta Recent Development Table 90. GenScript Company Details Table 91. GenScript Business Overview Table 92. GenScript CRISPR/Cas9 Product Table 93. GenScript Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 94. GenScript Recent Development Table 95. GeneCopoeia Company Details Table 96. GeneCopoeia Business Overview Table 97. GeneCopoeia CRISPR/Cas9 Product Table 98. GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 99. GeneCopoeia Recent Development Table 100. Synthego Company Details Table 101. Synthego Business Overview Table 102. Synthego CRISPR/Cas9 Product Table 103. Synthego Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Table 104. Synthego Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. CRISPR/Cas9 Product Picture Figure 2. Global CRISPR/Cas9 Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global CRISPR/Cas9 Market Size 2017-2028 (US$ Million) Figure 4. United States CRISPR/Cas9 Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States CRISPR/Cas9 Market Size 2017-2028 (US$ Million) Figure 6. United States CRISPR/Cas9 Market Share in Global 2017-2028 Figure 7. CRISPR/Cas9 Report Years Considered Figure 8. Product Picture of Genome Editing Figure 9. Product Picture of Genetic Engineering Figure 10. Product Picture of gRNA Database/Gene Librar Figure 11. Product Picture of CRISPR Plasmid Figure 12. Product Picture of Human Stem Cells Figure 13. Product Picture of Genetically Modified Organisms/Crops Figure 14. Product Picture of Cell Line Engineering Figure 15. Global CRISPR/Cas9 Market Share by Type in 2022 & 2028 Figure 16. Global CRISPR/Cas9 Market Size by Type (2017-2028) & (US$ Million) Figure 17. Global CRISPR/Cas9 Market Share by Type (2017-2028) Figure 18. United States CRISPR/Cas9 Market Share by Type in 2022 & 2028 Figure 19. United States CRISPR/Cas9 Market Size by Type (2017-2028) & (US$ Million) Figure 20. United States CRISPR/Cas9 Market Share by Type (2017-2028) Figure 21. Product Picture of Biotechnology Companies Figure 22. Product Picture of Pharmaceutical Companies Figure 23. Product Picture of Academic Institutes Figure 24. Product Picture of Research and Development Institutes Figure 25. Global CRISPR/Cas9 Market Share by Application in 2022 & 2028 Figure 26. Global CRISPR/Cas9 Market Size by Application (2017-2028) & (US$ Million) Figure 27. Global CRISPR/Cas9 Market Share by Application (2017-2028) Figure 28. United States CRISPR/Cas9 Market Share by Application in 2022 & 2028 Figure 29. United States CRISPR/Cas9 Market Size by Application (2017-2028) & (US$ Million) Figure 30. United States CRISPR/Cas9 Market Share by Application (2017-2028) Figure 31. North America CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. U.S. CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Canada CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Europe CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. Germany CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. France CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. U.K. CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Italy CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Russia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Asia-Pacific CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million) Figure 41. China CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Japan CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. South Korea CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. India CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Australia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Taiwan CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Indonesia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Thailand CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Malaysia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Philippines CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Latin America CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Mexico CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Brazil CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Argentina CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Middle East & Africa CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million) Figure 56. Turkey CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Saudi Arabia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 58. U.A.E CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million) Figure 59. Caribou Biosciences Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 60. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 61. CRISPR Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 62. Merck Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 63. Mirus Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 64. Editas Medicine Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 65. Takara Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 66. Thermo Fisher Scientific Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 67. Horizon Discovery Group Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 68. Intellia Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 69. Agilent Technologies Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 70. Cellecta Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 71. GenScript Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 72. GeneCopoeia Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 73. Synthego Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed
Caribou Biosciences Integrated DNA Technologies(IDT) CRISPR Therapeutics Merck Mirus Bio Editas Medicine Takara Bio Thermo Fisher Scientific Horizon Discovery Group Intellia Therapeutics Agilent Technologies Cellecta GenScript GeneCopoeia Synthego
Laboratory Balances market is segmented by region (country), players, by Type and by Application. ... Read More
NCA Battery(Lithium Nickel Cobalt Aluminum Oxide Battery) market is segmented by region (country) ... Read More
Cooking and Baking Papers market is segmented by region (country), players, by Type and by Applic ... Read More
Chlorine Gas Detector market is segmented by region (country), players, by Type and by Applicatio ... Read More